DKC1 Overexpression Induces a More Aggressive Cellular Behavior and Increases Intrinsic Ribosomal Activity in Immortalized Mammary Gland Cells

• Published in: Cancers Vol. 12; no. 12; p. 3512
• Main Authors: Guerrieri, Ania Naila, Zacchini, Federico, Onofrillo, Carmine, Di Viggiano, Sara, Penzo, Marianna, Ansuini, Alessio, Gandin, Ilaria, Nobe, Yuko, Taoka, Masato, Isobe, Toshiaki, Treré, Davide, Montanaro, Lorenzo
• Format: Journal Article
• Language: English
• Published: MDPI AG 25.11.2020; MDPI
• Subjects: breast cancer; Breast cancer; DKC1; Dyskerin; Prognosis; Pseudouridylation; RRNA; SnoRNA; DKC1; dyskerin; dyskerin; DKC1; breast cancer; prognosis; snoRNA; rRNA; pseudouridylation; Prognosi; prognosis; pseudouridylation; RRNA; SnoRNA
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers12123512

Dyskerin is a nucleolar protein involved in the small nucleolar RNA (snoRNA)-guided pseudouridylation of specific uridines on ribosomal RNA (rRNA), and in the stabilization of the telomerase RNA component (hTR). Loss of function mutations in DKC1 causes X-linked dyskeratosis congenita, which is characterized by a failure of proliferating tissues and increased susceptibility to cancer. However, several tumors show dyskerin overexpression. We observed that patients with primary breast cancers with high dyskerin levels are more frequently characterized by shorter survival rates and positive lymph node status than those with tumors with a lower dyskerin expression. To functionally characterize the effects of high dyskerin expression, we generated stably overexpressing DKC1 models finding that increased dyskerin levels conferred a more aggressive cellular phenotype in untransformed immortalized MCF10A cells. Contextually, DKC1 overexpression led to an upregulation of some snoRNAs, including SNORA67 and a significantly increased U1445 modification on 18S rRNA, the known target of SNORA67. Lastly, we found that dyskerin overexpression strongly enhanced the synthetic activity of ribosomes increasing translational efficiency in MCF10A. Altogether, our results indicate that dyskerin may sustain the neoplastic phenotype from an early stage in breast cancer endowing ribosomes with an augmented translation efficiency.